Investigational Drug Information for Tocotrienol
✉ Email this page to a colleague
What is the drug development status for Tocotrienol?
Tocotrienol is an investigational drug.
There have been 23 clinical trials for Tocotrienol.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.
The most common disease conditions in clinical trials are Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, and Pancreatic Neoplasms. The leading clinical trial sponsors are Vejle Hospital, Texas Tech University Health Sciences Center, and National Cancer Institute (NCI).
Summary for Tocotrienol
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 2,953 |
| WIPO Patent Applications | 1,078 |
| Japanese Patent Applications | 3,066 |
| Clinical Trial Progress | Phase 2 (2016-01-01) |
| Vendors | 4 |
Recent Clinical Trials for Tocotrienol
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL) | Hovid Berhad | Phase 2 |
| Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL) | Monash University Malaysia | Phase 2 |
| Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL) | Yuen Kah Hay | Phase 2 |
Clinical Trial Summary for Tocotrienol
Top disease conditions for Tocotrienol
Top clinical trial sponsors for Tocotrienol
US Patents for Tocotrienol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
